18 results
8-K
EX-1.1
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
of such data from such sources.
(xxxix) Cybersecurity. (A) There has been no security breach or incident, unauthorized access or disclosure, or other … to result in, any security breach or incident, unauthorized access or disclosure or other compromise to its IT Systems and Data; and (C) the Company
8-K
EX-1.1
ABOS
Acumen Pharmaceuticals Inc
27 Apr 23
Entry into a Material Definitive Agreement
7:02am
Sales Agreement, the Company will pay or cause to be paid all expenses incident to the performance of the Company’s obligations under this Amendment
S-3
EX-1.2
ABOS
Acumen Pharmaceuticals Inc
1 Jul 22
Shelf registration
5:06pm
. (A) There has been no security breach or incident, unauthorized access or disclosure, or other compromise of or relating to the Company’s information technology … of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or incident, unauthorized access
10-K
l5nylh3h
28 Mar 22
Annual report
4:51pm
10-Q
htn576ulw45
16 Aug 21
Quarterly report
4:51pm
8-K
EX-3.2
68djg
7 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:49pm
424B4
5nvq6p codisay
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-1.1
yix3xpk61mgdv14
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-3.4
62mn1ixy
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
13zryf8hc 4q
24 Jun 21
IPO registration (amended)
8:17am
S-1
esihsmcs88m
9 Jun 21
IPO registration
5:02pm
S-1
EX-3.2
o2wevch3x
9 Jun 21
IPO registration
5:02pm
DRS/A
h71e56w4xd
14 May 21
Draft registration statement (amended)
12:00am
DRS/A
EX-3.2
crkh89r5p lnc
14 May 21
Draft registration statement (amended)
12:00am
DRS
p2l0gllt0mf
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next